10 results
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Aplastic Anemia ... - Overview Who ... Damage to Marrow (Toxic ... anemia Treatment ... Anemia #oncology #hematology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
- Topical Treatment ... therapy is non-pharmacologic ... the first line pharmacologic ... Dermatitis #Topical #Treatment ... #Dermatology #Management
Sarcoidosis - Skin Manifestations

This is a quick overview of some of the cutaneous manifestations of sarcoidosis.
This is a quick overview ... article/1123970-overview ... /dermnetnz.org/topics ... #differential #treatment ... #photo #dermatology
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Atopic Dermatitis ... - Topical Treatment ... After non-pharmacologic ... #Medications #Pharmacology ... #Dermatology #Management
Chronic Lymphocytic Leukemia (CLL) - Summary
Overview: 
 • Most common leukemia in adults
 • Disorder of
CLL) - Summary Overview ... transformation) Treatment ... several RCTs have found ... AIHA, PRCA) • Treatment ... Leukemia #oncology #hematology
Disseminated Intravascular Coagulation (DIC) Overview

Increased Clotting and Consumption of Clotting Factors

Findings:
 • Bleeding
 • Recent history
Coagulation (DIC) Overview ... Bleeding from wound ... + Bleeding Treatment ... diagnosis #causes #treatment ... #management #hematology
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
Causes • Anemia • Aplastic ... factor (GCSF) treatments ... cells (blasts) are found ... marrow studies Treatment ... Syndromes #diagnosis #hematology
Chloramphenicol - Antibiotics Class Overview

– 50S ribosomal inhibitor.   IV or PO (but PO form
Antibiotics Class Overview ... beta-lactam allergy would ... Aplastic anemia ... #Pharmacology #Antibiotics ... #Review #Overview
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Sjogren's Syndrome Overview ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Sjogrens #Syndrome #Rheumatology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... effects in the treatment ... route • Highly toxic ... valleyfever #management #treatment ... comparison #table #pharmacology